Kymera Therapeutics (NASDAQ:KYMR) Director Sells $631,738.00 in Stock

The S&P 500 could hit bottom by May — and 6,000 is the stock market’s correction floor

US defense stocks see no Iran war lift after early surge

1 Year Since the Liberation Day Tariffs: This Surprising Stock Has Been the S&P 500's Top Performer

S&P 500’s War Pattern: The Wipeout Begins Every Thursday

Will the S&P 500 surge in the second quarter? The evidence is piling up, and it paints a compellingly clear picture.